转录学分析发现,埃兹林是宫癌和胃癌细胞中潜在的可药物点
Maria Fernanda Lopes Carvalho1, Carolina Santana Calicchio1, Bruna Oliveira de Almeida1
1Department of Pharmacology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brazil.
Clinics (Sao Paulo, Brazil)
|July 7, 2024
概括
这项研究表明,在宫癌和胃癌中,高埃兹林 (EZR) 表达与不良结果相关. 用NSC305787抑制埃兹林减少了癌细胞生长和促进细胞死亡,这表明埃兹林是潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 埃兹林 (EZR) 是一种在癌症中高度表达的蛋白质,它将细胞骨与细胞膜连接起来,并影响瘤发生.
- EZR在信号传导途径中发挥作用,对癌症进展至关重要.
- 药理上抑制埃兹林显示出潜在的抗瘤作用.
研究的目的:
- 通过使用TCGA数据,对32种癌症类型的EZR mRNA水平进行调查.
- 评估EZR转录水平与宫状细胞癌和胃腺癌的临床结果的相关性.
- 在细胞模型中评估以斯林抑制剂NSC305787的抗癌作用.
主要方法:
- 对ETRmRNA表达的TCGA数据进行全癌症分析.
- 对EZR水平与临床结果和基因表达特征的相关性分析.
- 用NSC305787.7进行宫和胃癌细胞系的体外治疗.
- 细胞和分子测试以评估药物的疗效,包括细胞活力,克隆生长,细胞亡和DNA损伤标记.
主要成果:
- 在宫平细胞癌和胃腺癌中,EZR mRNA的高度表达,与相关的分子过程相关.
- 在宫癌和胃癌细胞模型中,用NSC305787治疗显著降低了细胞活力和克隆生长 (p < 0.05).
- 药理性埃兹林抑制诱导了细胞死亡和DNA损伤的标记物,同时促进了与亡相关的基因并抑制了生存/增殖基因.
结论:
- 埃兹林 (EZR) 是一种新型抗癌疗法的有前途的分子标.
- 向埃兹林可能是治疗宫癌和胃癌的可行策略.
- 根据这些发现,对抗EZR疗法的进一步研究是有必要的.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K


